Monday 12 October 2026
Export all AMGN data to Excel Powerpack
Amgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024. In the quarter to June 2026, revenue grew 9.53%, EPS grew 65.4%, free cash flow grew 82.6% and total debt rose 1.96%, each against the same quarter a year earlier. Member of the S&P 500, Nasdaq 100 and Dow Jones; dividend growth for ten consecutive years, revenue growth for five.
414.87
7.43
+1.82%
Follow AMGN
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
14.61 | 67.30 | 15.34 | 18.62 | 18.56 | 21.72 | 21.48 | 23.68 | 34.20 | 22.84 |
Piotroski F-Score |
8 | 6 | 8 | 6 | 6 | 6 | 6 | 5 | 5 | 7 |
P/S ratio |
4.90 | 5.66 | 5.42 | 6.24 | 5.30 | 4.94 | 5.35 | 5.64 | 4.19 | 4.79 |
Altman Z-Score |
2.62 | 2.61 | 2.36 | 2.29 | 2.10 | 1.83 | 1.77 | 1.34 | 1.26 | 1.69 |
Altman Z″-Score (non-manufacturers) |
4.43 | 4.44 | 2.78 | 0.74 | 1.04 | 0.43 | 0.27 | 0.53 | 0.05 | 0.14 |
P/FCF ratio |
12.28 | 12.84 | 12.71 | 18.01 | 14.25 | 16.14 | 16.86 | 22.98 | 14.05 | 22.97 |
Beneish M-Score |
(2.65) | (3.02) | (2.62) | (2.18) | (2.65) | (2.65) | (2.63) | (2.26) | (2.83) | (2.27) |
P/Operating CF |
36.37 | 42.96 | 40.29 | 58.01 | 62.58 | 45.67 | 53.14 | 295.73 | 29.34 | 109.85 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 56 |
P/B ratio |
3.77 | 5.13 | 10.29 | 15.08 | 14.32 | 19.14 | 38.45 | 25.53 | 23.82 | 20.34 |
Price to Tangible BV |
23.27 | 69.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
4.75 | 5.39 | 5.61 | 7.14 | 6.18 | 5.91 | 6.47 | 7.55 | 5.63 | 6.03 |
EV/EBITDA |
9.18 | 10.32 | 10.92 | 14.04 | 12.33 | 13.91 | 13.13 | 16.60 | 14.46 | 14.34 |
EV/Operating CF |
10.55 | 11.01 | 11.80 | 18.23 | 14.96 | 16.58 | 17.53 | 25.12 | 16.37 | 22.25 |
EV/FCF |
11.90 | 12.21 | 13.17 | 20.60 | 16.61 | 19.32 | 20.41 | 30.73 | 18.88 | 28.90 |
Quick Ratio |
3.68 | 4.98 | 2.44 | 1.01 | 1.30 | 1.06 | 0.95 | 0.99 | 0.81 | 0.73 |
Current Ratio |
4.11 | 5.49 | 2.79 | 1.44 | 1.81 | 1.59 | 1.41 | 1.65 | 1.26 | 1.14 |
Net Debt/EBITDA |
(0.29) | (0.53) | 0.38 | 1.77 | 1.75 | 2.29 | 2.28 | 4.19 | 3.70 | 2.94 |
Debt/Assets |
44.57% | 44.20% | 51.09% | 50.08% | 52.40% | 54.46% | 59.80% | 66.51% | 65.44% | 60.28% |
Debt/Equity |
1.16 | 1.40 | 2.71 | 3.09 | 3.51 | 4.97 | 10.64 | 10.37 | 10.23 | 6.31 |
Asset Turnover |
0.31 | 0.29 | 0.32 | 0.37 | 0.41 | 0.42 | 0.42 | 0.35 | 0.35 | 0.40 |
Operating CF/Net income |
1.34 | 5.65 | 1.35 | 1.17 | 1.45 | 1.57 | 1.48 | 1.26 | 2.81 | 1.29 |
Capex/Depreciation |
(0.35) | (0.34) | (0.38) | (0.28) | (0.17) | (0.26) | (0.27) | (0.23) | (0.19) | (0.29) |
Interest Coverage |
7.77 | 7.65 | 7.37 | 7.51 | 7.24 | 6.38 | 6.80 | 2.75 | 2.30 | 3.30 |
| 26.65% | 7.18% | 44.48% | 70.73% | 76.13% | 73.16% | 126.47% | 135.79% | 67.55% | 106.10% | |
| 10.36% | 2.51% | 11.47% | 12.44% | 11.84% | 9.50% | 10.38% | 8.28% | 4.33% | 8.45% | |
ROIC |
23.20% | 32.97% | 37.46% | 19.72% | 17.99% | 14.93% | 17.95% | 8.24% | 8.40% | 10.48% |
Return on Tangible Assets |
19.42% | 4.35% | 28.86% | 74.45% | 50.51% | 47.58% | 54.94% | 37.57% | 32.79% | 67.16% |
Average Days of Receivables |
50.25 | 51.71 | 55.03 | 63.39 | 64.96 | 68.77 | 77.14 | 94.11 | 74.06 | 95.05 |
Research and Development Expense of Revenue |
16.70% | 15.59% | 15.74% | 17.62% | 16.55% | 18.55% | 16.84% | 16.97% | 17.84% | 19.79% |
Selling, General and Administrative Expense of Revenue |
22.02% | 21.31% | 22.45% | 22.04% | 22.54% | 20.66% | 20.57% | 21.92% | 21.23% | 19.18% |
Intangible Assets out of Total Assets |
0.32 | 0.29 | 0.33 | 0.57 | 0.50 | 0.49 | 0.49 | 0.53 | 0.50 | 0.45 |
Share Based Compensation of Revenue |
1.35% | 1.44% | 1.31% | 1.32% | 1.30% | 1.31% | 1.52% | 1.53% | 1.59% | 1.34% |
Graham Net Nets |
(0.02) | (0.04) | (0.13) | (0.22) | (0.24) | (0.27) | (0.28) | (0.38) | (0.41) | (0.30) |
Graham Number |
96.30 | 45.20 | 73.48 | 68.25 | 66.90 | 52.34 | 43.18 | 57.38 | 43.32 | 72.03 |
Earnings Yield |
6.85% | 1.49% | 6.52% | 5.37% | 5.39% | 4.61% | 4.66% | 4.22% | 2.92% | 4.38% |
Free Cash Flow Yield |
8.14% | 7.79% | 7.87% | 5.55% | 7.02% | 6.20% | 5.93% | 4.35% | 7.12% | 4.35% |
Revenue per Share |
30.74 | 31.26 | 35.93 | 38.61 | 43.39 | 45.58 | 48.93 | 52.69 | 62.24 | 68.31 |
Operating CF per Share |
13.84 | 15.29 | 17.09 | 15.12 | 17.91 | 16.25 | 18.07 | 15.83 | 21.40 | 18.51 |
Capex per Share |
(0.99) | (0.91) | (1.12) | (1.02) | (1.04) | (1.54) | (1.74) | (2.08) | (2.04) | (3.45) |
Free Cash Flow per Share |
12.86 | 14.38 | 15.97 | 14.10 | 16.88 | 14.70 | 16.33 | 13.76 | 19.36 | 15.06 |
Cash per Share |
50.92 | 57.02 | 44.33 | 14.73 | 18.17 | 14.10 | 17.30 | 20.46 | 22.30 | 16.97 |
Shareholders Equity per Share |
39.94 | 34.53 | 18.91 | 15.99 | 16.06 | 11.75 | 6.80 | 11.65 | 10.94 | 16.09 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
39.94 | 34.53 | 18.91 | 15.99 | 16.06 | 11.75 | 6.80 | 11.65 | 10.94 | 16.09 |
Free Cash Flow |
9,616.00 | 10,513.00 | 10,558.00 | 8,532.00 | 9,889.00 | 8,381.00 | 8,785.00 | 7,359.00 | 10,394.00 | 8,100.00 |
Working Capital |
34,806.00 | 40,456.00 | 24,130.00 | 5,605.00 | 9,491.00 | 7,201.00 | 6,499.00 | 11,940.00 | 5,931.00 | 3,568.00 |
Capital Expenditures |
(738.00) | (664.00) | (738.00) | (618.00) | (608.00) | (880.00) | (936.00) | (1,112.00) | (1,096.00) | (1,858.00) |
Net Current Asset Value |
(1,741.00) | (5,237.00) | (16,298.00) | (31,594.00) | (32,395.00) | (35,080.00) | (39,274.00) | (60,590.00) | (56,932.00) | (52,871.00) |
EV/EBIT |
11.16 | 12.34 | 12.99 | 17.25 | 17.19 | 20.09 | 17.81 | 26.94 | 25.91 | 24.40 |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | 0.02 | 0.03 | 0.04 | 0.04 | 0.03 | 0.05 |
Price to Operating Income |
11.51 | 12.97 | 12.54 | 15.08 | 14.74 | 16.79 | 14.72 | 20.15 | 19.28 | 19.39 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.42 | 0.39 | 0.39 | 0.45 | 0.74 | 0.66 | 0.63 | 0.83 | 0.88 | 0.80 |
Cash ROIC |
9.38% | 10.28% | 13.94% | 17.60% | 18.64% | 17.44% | 16.92% | 9.00% | 13.33% | 11.19% |
Accounts Receivable Turnover |
7.46 | 7.14 | 6.97 | 6.12 | 5.93 | 5.52 | 5.03 | 4.39 | 4.76 | 4.50 |
Accounts Payable Turnover |
4.42 | 3.59 | 3.21 | 3.38 | 4.41 | 4.63 | 4.36 | 5.35 | 7.35 | 5.63 |
Inventory Turnover |
1.61 | 1.46 | 1.42 | 1.34 | 1.65 | 1.62 | 1.42 | 1.17 | 1.56 | 1.82 |
Average Days of Payables |
80.42 | 121.28 | 107.43 | 114.88 | 84.21 | 77.25 | 89.57 | 68.67 | 54.16 | 71.77 |
Days of Inventory on Hand |
240.73 | 254.22 | 261.67 | 300.31 | 230.71 | 231.08 | 280.90 | 411.08 | 198.65 | 188.76 |
Average Receivables |
3,080.00 | 3,201.00 | 3,408.50 | 3,818.50 | 4,291.00 | 4,710.00 | 5,229.00 | 6,415.50 | 7,025.00 | 8,176.00 |
Average Payables |
941.00 | 1,134.50 | 1,279.50 | 1,289.00 | 1,396.00 | 1,393.50 | 1,469.00 | 1,581.00 | 1,749.00 | 2,137.50 |
Average Inventory |
2,590.00 | 2,789.50 | 2,887.00 | 3,262.00 | 3,738.50 | 3,989.50 | 4,508.00 | 7,224.00 | 8,258.00 | 6,611.50 |
Average Assets |
74,537.50 | 78,790.00 | 73,185.00 | 63,061.50 | 61,327.50 | 62,056.50 | 63,143.00 | 81,137.50 | 94,496.50 | 91,212.50 |
Average Common Equity |
28,979.00 | 27,558.00 | 18,870.50 | 11,086.50 | 9,541.00 | 8,054.50 | 5,180.50 | 4,946.50 | 6,054.50 | 7,267.50 |
Columns are period end dates